Back to Search Start Over

Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium

Authors :
Karin Wirdefeldt
Brian K. Fiske
Chin-Hsien Lin
Jessie Theuns
Young H. Sohn
Nadine Abahuni
Simone Van De Loo
Vera Tadic
Jonathan Carr
John P. A. Ioannidis
Simona Petrucci
Jan O. Aasly
Grazia Annesi
Matthew J. Farrer
Hiroyuki Tomiyama
Demetrius M. Maraganore
Suzanne Lesage
Sung Sup Park
Magdalena Boczarska-Jedynak
Zbigniew K. Wszolek
Dennis W. Dickson
Elli Kyratzi
Peter A. Silburn
Nancy N. Diehl
Alexis Brice
Leonidas Stefanis
Enza Maria Valente
Marie-Christine Chartier-Harlin
J. Mark Gibson
Ruey-Meei Wu
Christine Klein
Nobutaka Hattori
Andreas Puschmann
George D. Mellick
Georgios M. Hadjigeorgiou
Alexandra I. Soto-Ortolaza
Beom S. Jeon
Aldo Quattrone
Christine Van Broeckhoven
Efthimios Dardiotis
Demetrios K. Vassilatis
Laura Brighina
Maria Bozi
Yun Joong Kim
Christer Nilsson
Justin A. Bacon
Ryan J. Uitti
Eugénie Mutez
Soraya Bardien
Carles Vilariño-Güell
Michael G. Heckman
Rejko Krüger
Manu Sharma
Rachel A. Gibson
Timothy Lynch
Linda R. White
Barbara Jasinska-Myga
Fayçal Hentati
Carlo Ferrarese
Grzegorz Opala
Owen A. Ross
Alexis Elbaz
Source :
Movement Disorders. 28:1740-1744
Publication Year :
2013
Publisher :
Wiley, 2013.

Abstract

BackgroundVariants within the leucine-rich repeat kinase 2 gene are recognized as the most frequent genetic cause of Parkinson's disease. Leucine-rich repeat kinase 2 variation related to disease susceptibility displays many features that reflect the nature of complex, late-onset sporadic disorders like Parkinson's disease. MethodsThe Genetic Epidemiology of Parkinson's Disease Consortium recently performed the largest genetic association study for variants in the leucine-rich repeat kinase 2 gene across 23 different sites in 15 countries. ResultsHerein, we detail the allele frequencies for the novel risk factors (p.A419V and p.M1646T) and the protective haplotype (p.N551K-R1398H-K1423K) nominated in the original publication. Simple population allele frequencies not only can provide insight into the clinical relevance of specific variants but also can help genetically define patient groups. ConclusionsEstablishing individual patient-based genomic susceptibility profiles that incorporate both risk factors and protective factors will determine future diagnostic and treatment strategies. (c) 2013 International Parkinson and Movement Disorder Society (Less)

Details

ISSN :
08853185
Volume :
28
Database :
OpenAIRE
Journal :
Movement Disorders
Accession number :
edsair.doi...........ecfdc887c7af5e9fa70021227ff3ad13
Full Text :
https://doi.org/10.1002/mds.25600